Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 2 |
2022 | 1 |
2023 | 2 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
To go or not to go? Biological logic gating engineered T cells.
J Immunother Cancer. 2022 Apr;10(4):e004185. doi: 10.1136/jitc-2021-004185.
J Immunother Cancer. 2022.
PMID: 35379738
Free PMC article.
Review.
Finding the Keys to the CAR: Identifying Novel Target Antigens for T Cell Redirection Immunotherapies.
Abbott RC, Cross RS, Jenkins MR.
Abbott RC, et al.
Int J Mol Sci. 2020 Jan 14;21(2):515. doi: 10.3390/ijms21020515.
Int J Mol Sci. 2020.
PMID: 31947597
Free PMC article.
Review.
Item in Clipboard
Human EGFRvIII chimeric antigen receptor T cells demonstrate favorable safety profile and curative responses in orthotopic glioblastoma.
Abbott RC, Iliopoulos M, Watson KA, Arcucci V, Go M, Hughes-Parry HE, Smith P, Call MJ, Cross RS, Jenkins MR.
Abbott RC, et al.
Clin Transl Immunology. 2023 Mar 5;12(3):e1440. doi: 10.1002/cti2.1440. eCollection 2023.
Clin Transl Immunology. 2023.
PMID: 36890859
Free PMC article.
Item in Clipboard
Endogenous H3.3K27M derived peptide restricted to HLA-A∗02:01 is insufficient for immune-targeting in diffuse midline glioma.
Wang SS, Pandey K, Watson KA, Abbott RC, Mifsud NA, Gracey FM, Ramarathinam SH, Cross RS, Purcell AW, Jenkins MR.
Wang SS, et al. Among authors: abbott rc.
Mol Ther Oncolytics. 2023 Aug 15;30:167-180. doi: 10.1016/j.omto.2023.08.005. eCollection 2023 Sep 21.
Mol Ther Oncolytics. 2023.
PMID: 37674626
Free PMC article.
Item in Clipboard
Novel high-affinity EGFRvIII-specific chimeric antigen receptor T cells effectively eliminate human glioblastoma.
Abbott RC, Verdon DJ, Gracey FM, Hughes-Parry HE, Iliopoulos M, Watson KA, Mulazzani M, Luong K, D'Arcy C, Sullivan LC, Kiefel BR, Cross RS, Jenkins MR.
Abbott RC, et al.
Clin Transl Immunology. 2021 May 9;10(5):e1283. doi: 10.1002/cti2.1283. eCollection 2021.
Clin Transl Immunology. 2021.
PMID: 33976881
Free PMC article.
Item in Clipboard
Erratum: Novel high-affinity EGFRvIII-specific chimeric antigen receptor T cells effectively eliminate human glioblastoma.
Abbott RC, Verdon DJ, Gracey FM, Hughes-Parry HE, Iliopoulos M, Watson KA, Mulazzani M, Luong K, D'Arcy C, Sullivan LC, Kiefel BR, Cross RS, Jenkins MR.
Abbott RC, et al.
Clin Transl Immunology. 2021 Jul 18;10(7):e1317. doi: 10.1002/cti2.1317. eCollection 2021.
Clin Transl Immunology. 2021.
PMID: 34295472
Free PMC article.
Item in Clipboard
Cite
Cite